Your browser doesn't support javascript.
loading
Dramatic Antitumor Activity of Nivolumab in Advanced HER2-Positive Lung Cancer.
Catania, Chiara; Passaro, Antonio; Rocco, Elena Guerini; Spitaleri, Gianluca; Barberis, Massimo; Noberasco, Cristina; Signore, Ester Del; Travaini, Laura; de Marinis, Filippo.
Afiliación
  • Catania C; Thoracic Division, Medical Oncology Department, European Institute of Oncology, Milan, Italy. Electronic address: chiara.catania@ieo.it.
  • Passaro A; Thoracic Division, Medical Oncology Department, European Institute of Oncology, Milan, Italy.
  • Rocco EG; Division of Pathology, European Institute of Oncology, Milan, Italy.
  • Spitaleri G; Thoracic Division, Medical Oncology Department, European Institute of Oncology, Milan, Italy.
  • Barberis M; Division of Pathology, European Institute of Oncology, Milan, Italy.
  • Noberasco C; Thoracic Division, Medical Oncology Department, European Institute of Oncology, Milan, Italy.
  • Signore ED; Thoracic Division, Medical Oncology Department, European Institute of Oncology, Milan, Italy.
  • Travaini L; Division of Nuclear Medicine, European Institute of Oncology, Milan, Italy.
  • de Marinis F; Thoracic Division, Medical Oncology Department, European Institute of Oncology, Milan, Italy.
Clin Lung Cancer ; 17(5): e179-e183, 2016 09.
Article en En | MEDLINE | ID: mdl-27349506
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Adenocarcinoma / Receptor ErbB-2 / Neoplasias Pulmonares / Anticuerpos Monoclonales / Antineoplásicos Límite: Female / Humans / Middle aged Idioma: En Revista: Clin Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2016 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Adenocarcinoma / Receptor ErbB-2 / Neoplasias Pulmonares / Anticuerpos Monoclonales / Antineoplásicos Límite: Female / Humans / Middle aged Idioma: En Revista: Clin Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2016 Tipo del documento: Article Pais de publicación: Estados Unidos